Advanced Search

Study Preview



Study Title and Description

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.



Key Questions Addressed
1 Key Question 1. In adult women without preexisting breast cancer, what is the accuracy of risk assessment methods to identify women who could benefit from medications to reduce risk for primary breast cancer (e.g., clinical risk assessment models)? Key Question 1a. What is the optimal age at which to begin risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer? Key Question 1b. What is the optimal frequency of risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Author Li K., Anderson G., Viallon V., Arveux P., Kvaskoff M., Fournier A., Krogh V., Tumino R., Sánchez MJ., Ardanaz E., Chirlaque MD., Agudo A., Muller DC., Smith T., Tzoulaki I., Key TJ., Bueno-de-Mesquita B., Trichopoulou A., Bamia C., Orfanos P., Kaaks R., Hüsing A., Fortner RT., Zeleniuch-Jacquotte A., Sund M., Dahm CC., Overvad K., Aune D., Weiderpass E., Romieu I., Riboli E., Gunter MJ., Dossus L., Prentice R., Ferrari P.
Country Nutritional Methodology and Biostatistics Group, Nutrition and Metabolism Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Year 2018
Numbers Pubmed ID: 30509329

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.